145 related articles for article (PubMed ID: 25815441)
1. Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro.
Wu A; Wu K; Li M; Bao L; Shen X; Li S; Li J; Yang Z
Mol Med Rep; 2015 Jul; 12(1):1413-20. PubMed ID: 25815441
[TBL] [Abstract][Full Text] [Related]
2. Demethylation of miR-10b plays a suppressive role in ccRCC cells.
He C; Zhao X; Jiang H; Zhong Z; Xu R
Int J Clin Exp Pathol; 2015; 8(9):10595-604. PubMed ID: 26617769
[TBL] [Abstract][Full Text] [Related]
3. miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Tumour Biol; 2015 Sep; 36(9):6875-82. PubMed ID: 25846734
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
6. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
8. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
10. Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
Chen D; Li Y; Yu Z; Su Z; Yu W; Li Y; Yang S; Gui Y; Ni L; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1399-404. PubMed ID: 25815587
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.
Xu B; Zhang L; Luo C; Qi Y; Cui Y; Ying JM; Zhang Q; Jin J
Int J Mol Sci; 2015 Jan; 16(1):1051-65. PubMed ID: 25569086
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.
Niu S; Ma X; Zhang Y; Liu YN; Chen X; Gong H; Yao Y; Liu K; Zhang X
PLoS One; 2018; 13(2):e0192790. PubMed ID: 29474434
[TBL] [Abstract][Full Text] [Related]
14. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.
Nie W; Ni D; Ma X; Zhang Y; Gao Y; Peng C; Zhang X
Int J Oncol; 2019 Feb; 54(2):559-571. PubMed ID: 30483771
[TBL] [Abstract][Full Text] [Related]
15. miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
Jingushi K; Ueda Y; Kitae K; Hase H; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
Mol Cancer Res; 2015 Mar; 13(3):565-74. PubMed ID: 25381221
[TBL] [Abstract][Full Text] [Related]
16. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.
Saito Y; Liang G; Egger G; Friedman JM; Chuang JC; Coetzee GA; Jones PA
Cancer Cell; 2006 Jun; 9(6):435-43. PubMed ID: 16766263
[TBL] [Abstract][Full Text] [Related]
17. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
18. MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma.
Wang M; Gao H; Qu H; Li J; Liu K; Han Z
Pharmacol Rep; 2018 Oct; 70(5):963-971. PubMed ID: 30107346
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.
Tian X; Wei Z; Wang J; Liu P; Qin Y; Zhong M
Oncol Rep; 2015 Aug; 34(2):707-14. PubMed ID: 26058485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
